DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cost of drug development
Cost of drug development
Expression Profiling / Microarray / Data Analysis at Amgen
Evidence Regarding Research and Development Investments in Innovative and Non-Innovative Medicines James Love Consumer Project on Technology September 22, 2003
Amgen's Complaint 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Setting Fair Prices for Life-Saving Drugs by Bruce A
Digital R&D: the Next Frontier for Biopharmaceuticals
Estimated Research and Development Investment Needed to Bring a New
Drug Pricing and Pharmaceutical Patenting Practices
Check out Our White Paper
The Pharmaceutical Industry
The R&D Cost of a New Medicine
Estimating the Clinical Cost of Drug Development for Orphan Versus Non
The Cost of Drug Development: a Systematic Review
Cardiovascular Disease Insights from the Oncology Drug Development Experience
Sanofi/Regeneron Extend a Hand on Praluent, Express Scripts Takes It
Life Sciences U.S. Trends and Developments
The Price of Innovation: New Estimates of Drug Development Costs Joseph A
Orphan Drugs in the United States
Unrealized Potential of Drug Repositioning in Europe During COVID-19 and Beyond: a Physician's Perspective A
Top View
Testimony Before the House Oversight Committee on Drug Prices
Pharmaceutical R&D: Costs, Risks, and Rewards
Reconsidering the Rationale for the Duration of Data Exclusivity
Pharmaceuticals: Merck
Costs of Discovering, Developing, Manufacturing and Marketing Biotechnology Products
Ending Stagnation: How Collaboration Tools Are Enabling a New Era of R&D
Phase 0/Microdosing Approaches
The Price of Innovation: New Estimates of Drug Development Costs Joseph A
FDA's Priority Review Voucher Programs
The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform
Reconsidering the Rationale for the Duration of Data Exclusivity
Nber Working Paper Series Private and Social Returns
New Estimates of Drug Development Costs A, B C Joseph A
Drug Value & Market Access Optimization
New Drugs Cost US$2.6 Billion to Develop
Examination of Clinical Trial Costs and Barriers for Drug Development Final
Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval
In the United States District Court for the Southern District of Florida
The Development of Orphan Drugs; a Financial and Ethical Decision
MEETING SUMMARY: Access to and Cost of Cancer Drugs in A